|
|
|
|
|
| IRB | | Title | | 07182 | | Timing of Rectal Cancer Response to Chemoradiation
Principal Investigator: Julio Garcia-Aguilar, M.D., Ph.D. | | 07158 | | Laparoscopic Versus Robotic-assisted Surgery for Rectal Cancer
Principal Investigator: Alessio Pigazzi, M.D., Ph.D. | | | | | | 06210 | | ECOG E5202: A Randomized Phase III Study Comparing 5-FU, Leucovorin, Oxaliplatin Versus 5-FU, Leucovorin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
Principal Investigator: Lily Lai, M.D. | | | | | | 06152 | | CALGB/SWOG C80405: A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
Principal Investigator: Stephen I. Shibata, M.D. | | | | | | 06060 | | NSABP Protocol C-10: A Phase II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6) Chemotherapy plus Bevacizumab for Patients with Unresectable Stage IV Colon Cancer and a Synchronous Asymptomatic Primary Tumor
Principal Investigator: Lily Lai, M.D. | | | | | | 05168 | | A Phase II Trial of Neoadjuvant Chemoradiation and Local Excision for uT2uN0 Rectal Cancer
Principal Investigator: Lily Lai, M.D. | | | | | | 04197 | | NSABP R-04: A Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion (CVI) of 5-Fluorouracil (5-FU) in the Treatment of Patients with Operable Carcinoma of the Rectum
Principal Investigator: Lily Lai, M.D. | | | | | | 04080 | | CTSU/NCCTG: N0147 A Randomized Phase III Trial of Oxaliplatin (OXAL) Plus 5-Fluorouracil (5-FU)/Leucovorin (CF) with or w/o Cetuximab (C225 after Curative Resection for Patients with Stage III
Colon Cancer
Principal Investigator: Stephen I. Shibata, M.D. | | | | |
For more information regarding the above listed clinical trials, please contact the individual physicians or go to http://clinicaltrials.coh.org and enter the IRB number.
|
|
|
